一个罕见的骨髓纤维化病例进展为BCR-ABL1-阳性慢性髓性白血病,具有不一致的分子检测
Himani Badyal1, Vallabh Dogra1, Ratika Dogra1
1Internal Medicine, St. Vincent's Medical Center, Toledo, USA.
Cureus
|July 30, 2025
概括
骨髓纤维化很少转化为慢性骨髓性白血病 (CML),但这种情况显示了可通过FISH检测的BCR-ABL1克隆,而不是PCR. 这凸显了在骨髓增殖性瘤中使用多种诊断方法的必要性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子诊断学 分子诊断学
背景情况:
- 骨髓纤维化 (MF) 是一种慢性骨髓扩散性瘤 (CMN),有可能转变为急性骨髓性白血病 (AML).
- 多发性瘤转化为慢性髓性白血病 (CML) 是罕见的,人们对其了解甚少.
- CML的特征是BCR-ABL1融合基因,通常通过FISH和RT-PCR检测到.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.6K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.1K
